Life ScienceCompany
Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines Ownership
Who owns Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines?
Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines is owned by Elanco Animal Health. It was acquired on October 5, 2016.
Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines Business Overview
Where is Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines headquartered?
Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines is headquartered in St. Joseph, Montana.
What sector is Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines in?
Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.